IPL 2023: Gujarat Titans introduce lavender kit in support of cancer battle for upcoming SRH clash in IPL 2023.
Gujarat Titans unveiled their lavender jerseys which they will wear during their last home game of the IPL 2023 on May 15 against SunRisers Hyderabad in support of the fight against cancer. “We are ready to don the lavender colours this Monday for a special cause. Gujarat Titans care about the health and wellness of one and all! Join us as we strive to raise awareness against cancer. #GTvSRH | #AavaDe | #TATAIPL 2023,” GT unveiled the jersey on social media.
The initiative aims to draw attention to the critical issue of cancer, which continues to be a major cause of morbidity and mortality in India and around the world. According to a press release, the use of lavender, a colour that represents all types of cancer, serves as a powerful reminder of the many lives affected by this devastating disease.
Gujarat Titans hope to raise awareness about the importance of early detection and prevention by wearing lavender jerseys, emphasising the critical role that lifestyle changes can play in cancer prevention, according to the team. The Hardik-led franchise hopes to inspire people to learn more about cancer prevention and the necessary lifestyle changes, as well as regular screening for early detection, which can significantly reduce the risk of developing the disease, through this initiative.
IPL 2023: “Cancer is a battle fought by millions in India and across the globe, and as a team, we feel responsible towards raising awareness about this deadly disease,” Gujarat Titans captain Hardik Pandya said. “Wearing lavender jerseys is our way of showing solidarity with cancer patients, survivors, and their families. We hope our actions will inspire others to take preventive measures and support those who are fighting this battle.”
Cancer is the world’s second most common cause of death, accounting for approximately 9.9 million deaths in 2020. Over the last decade, the global incidence of cancer increased by 26%, while cancer-related deaths increased by 21%.
